Research, Science & development
-
Insulet launches EVOLVE trial for fully closed-loop type 2 diabetes system
Insulet received Investigational Device Exemption approval from the U.S. Food and Drug Administration in March 2026, clearing the way for the trial to begin.
-
JOOTRH Study warns rising antibiotic resistance is undermining wound care treatment
The study found that resistance to commonly prescribed antibiotics, including ampicillin and cotrimoxazole, now exceeds 90% in some wound infection cases.
-
Mayo Clinic Study finds wearable sleep data may improve COPD pulmonary rehabilitation participation
The study suggests that tracking sleep patterns before rehabilitation begins could help healthcare teams identify patients who may need extra support to stay engaged throughout treatment.
-
Novo Nordisk oral semaglutide shows superior glycemic control in teens
The study showed that oral semaglutide achieved a significantly greater reduction in HbA1c levels, a key marker of blood sugar control, compared to placebo.
-
King Faisal Specialist Hospital & Research Center to lead global innovation at C3 Davos Silicon Valley Summit
The summit convenes senior executives from healthcare, biotechnology, artificial intelligence, academia, and investment firms under the theme “Healthtech Frontiers: Building the Health Ecosystem of Tomorrow.”
-
Sanofi’s Nuvaxovid exhibits 50% fewer severe side effects than Moderna’s mRNA booster
Less than 10% of participants in the Nuvaxovid group experienced severe side effects that interfered with daily activities compared with 20% in the mNexspike group.
-
AWS launches “Amazon Bio Discovery” to revolutionize antibody research
The platform offers a comprehensive suite of tools, including a library of AI models, advanced analytics packages, and an AI-powered agent that assists researchers in designing experiments.
-
NYU Abu Dhabi develops “Smart” theranostic molecules for cancer
The work centres on magnetic resonance imaging (MRI), a widely used diagnostic tool that allows doctors to visualise tumours inside the body.
-
AI Scans can predict fall risk in middle age, Mayo Clinic Study shows
Falls represent one of the most serious health threats facing older adults, yet Mayo Clinic scientists have found that warning signs may already be visible in imaging tests that people undergo for entirely different reasons.
-
Siemens-backed Study proves software-guided heart assessments are as effective as invasive wires
Results confirmed that Caas vFFR is a safe and effective alternative to conventional pressure wire-based physiology for guiding treatment decisions in patients with intermediate coronary artery stenosis.